September 23, 2020
The Ministry of Health, Labor and Welfare (MHLW) on September 18 granted orphan drug designations to five APIs including Nobelpharma’s sargramostim and Bristol Myers Squibb’s ipilimumab. Sargramostim earned the status for the proposed indications of autoimmune alveolar proteinosis and ipilimumab...read more